{"contacts": [{"terms": [{"accession": "MS:1002037", "name": "dataset submitter"}, {"accession": "MS:1000586", "name": "contact name", "value": "Alexandre Rosa Campos"}, {"accession": "MS:1000589", "name": "contact email", "value": "arosacampos@sbpdiscovery.org"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "SBP Medical Discovery Institute"}]}, {"terms": [{"accession": "MS:1002332", "name": "lab head"}, {"accession": "MS:1000586", "name": "contact name", "value": "Timothy Y. Huang"}, {"accession": "MS:1000589", "name": "contact email", "value": "thuang@sbpdiscovery.org"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "Sanford Burnham Prebys Medical Discovery Institute"}]}], "description": "SORLA is a type I transmembrane component associated with Alzheimers disease (AD) risk. Although SORLA is abundantly expressed in neurons, physiological roles for SORLA remain yet unclear. Here, we show that cultured neurons overexpressing SORLA (SORLA TG) feature enhanced neurite length, and accelerated neurite regeneration with wounding. Enhanced accumulation of a soluble SORLA form (sSORLA) is observed in SORLA TG neurons, where purified sSORLA can sufficiently drive neurite extension and regeneration. Phosphoproteomic analysis indicates enrichment of phosphoproteins related to the EGFR/ERK pathway in SORLA TG hippocampus. We find that sSORLA can co-precipitate with EGFR in vitro, where sSORLA treatment can induce EGFR Y1173 phosphorylation in cultured neurons. sSORLA also triggers Erk activation and downstream c-fos upregulation/nuclear translocation, where pharmacological EGFR or ERK inhibition reversed enhancements in sSORLA-dependent neurite regeneration. Together, these results implicate the EGFR as a sSORLA receptor which activates ERK/c-Fos pathways to enhance neurite extension, outgrowth and regeneration.   ", "fullDatasetLinks": [{"accession": "MS:1002488", "name": "MassIVE dataset URI", "value": "http://massive.ucsd.edu/ProteoSAFe/dataset.jsp?task=7db9ee7fdbaa45bc8701b9dfdac98193"}, {"accession": "MS:1002852", "name": "Dataset FTP location", "value": "ftp://massive.ucsd.edu/MSV000085400/"}], "identifiers": [{"accession": "MS:1002487", "name": "MassIVE dataset identifier", "value": "MSV000085400"}, {"accession": "MS:1001919", "name": "ProteomeXchange accession number", "value": "PXD019109"}, {"accession": "MS:1001921", "name": "ProteomeXchange accession number version number", "value": "1"}], "instruments": [{"accession": "MS:1002732", "name": "Orbitrap Fusion Lumos"}], "keywords": [{"accession": "MS:1001925", "name": "submitter keyword", "value": "Alzheimers disease"}, {"accession": "MS:1001925", "name": "submitter keyword", "value": "SORLA"}], "modifications": [{"accession": "UNIMOD:21", "name": "Phospho"}], "publications": [{"terms": [{"accession": "MS:1002853", "name": "Dataset with no associated published manuscript"}]}], "species": [{"terms": [{"accession": "MS:1001469", "name": "taxonomy: scientific name", "value": "Mus musculus"}, {"accession": "MS:1001468", "name": "taxonomy: common name", "value": "house mouse"}, {"accession": "MS:1001467", "name": "taxonomy: NCBI TaxID", "value": "10090"}]}], "title": "Soluble SORLA enhances neurite outgrowth and regeneration through activation of EGFR and MAPK pathways"}